Optimizing Return and Secure Disposal of Prescription Opioids to Reduce the Diversion to Secondary Users and Black Market
Md Mahmudul Hasan, Tasnim Ibn Faiz, Alicia Sasser Modestino, Gary J., Young, Md. Noor-E-Alam

TL;DR
This paper presents a data-driven optimization framework using MINLP and Benders Decomposition to strategically locate opioid disposal kiosks and determine incentive plans, aiming to reduce opioid diversion and misuse.
Contribution
It introduces a novel optimization model for planning opioid disposal strategies, incorporating economic and healthcare costs, with a case study demonstrating its practical application.
Findings
Optimal kiosk locations improve disposal rates
Incentive disbursement plans significantly reduce diversion
Model offers trade-off strategies for policymakers
Abstract
Opioid Use Disorder (OUD) has reached an epidemic level in the US. Diversion of unused prescription opioids to secondary users and black market significantly contributes to the abuse and misuse of these highly addictive drugs, leading to the increased risk of OUD and accidental opioid overdose within communities. Hence, it is critical to design effective strategies to reduce the non-medical use of opioids that can occur via diversion at the patient level. In this paper, we aim to address this critical public health problem by designing strategies for the return and safe disposal of unused prescription opioids. We propose a data-driven optimization framework to determine the optimal incentive disbursement plans and locations of easily accessible opioid disposal kiosks to motivate prescription opioid users of diverse profiles in returning their unused opioids. We develop a Mixed-Integer…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsOpioid Use Disorder Treatment · HIV, Drug Use, Sexual Risk · Prenatal Substance Exposure Effects
